Boiron SA (BOI) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.076x

Based on the latest financial reports, Boiron SA (BOI) has a cash flow conversion efficiency ratio of 0.076x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€28.13 Million ≈ $32.88 Million USD) by net assets (€369.12 Million ≈ $431.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Boiron SA - Cash Flow Conversion Efficiency Trend (2001–2024)

This chart illustrates how Boiron SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Boiron SA (BOI) financial obligations for a breakdown of total debt and financial obligations.

Boiron SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boiron SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
BAIC Motor Corp Ltd
F:2B5
0.086x
First Mining Gold Corp
TO:FF
-0.006x
Guilin Tourism Corp Ltd
SHE:000978
0.059x
Zhejiang Xinchai Co. Ltd.
SHE:301032
N/A
I-Mab
NASDAQ:IMAB
0.007x
Fortune Ng Fung Food Hebei Co Ltd
SHG:600965
0.016x
Hampidjan hf
IC:HAMP
0.016x
Konya Cimento Sanayi AS
IS:KONYA
-0.051x

Annual Cash Flow Conversion Efficiency for Boiron SA (2001–2024)

The table below shows the annual cash flow conversion efficiency of Boiron SA from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Boiron SA.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €378.18 Million
≈ $442.14 Million
€39.53 Million
≈ $46.22 Million
0.105x -10.04%
2023-12-31 €391.50 Million
≈ $457.70 Million
€45.49 Million
≈ $53.18 Million
0.116x +10.35%
2022-12-31 €557.35 Million
≈ $651.60 Million
€58.69 Million
≈ $68.61 Million
0.105x +68.07%
2021-12-31 €531.77 Million
≈ $621.70 Million
€33.32 Million
≈ $38.95 Million
0.063x -53.27%
2020-12-31 €509.17 Million
≈ $595.27 Million
€68.27 Million
≈ $79.81 Million
0.134x +33.25%
2019-12-31 €505.46 Million
≈ $590.94 Million
€50.86 Million
≈ $59.46 Million
0.101x -41.95%
2018-12-31 €486.04 Million
≈ $568.24 Million
€84.25 Million
≈ $98.50 Million
0.173x -14.36%
2017-12-31 €517.49 Million
≈ $605.00 Million
€104.75 Million
≈ $122.46 Million
0.202x -13.69%
2016-12-31 €469.60 Million
≈ $549.01 Million
€110.13 Million
≈ $128.75 Million
0.235x -5.42%
2015-12-31 €416.04 Million
≈ $486.40 Million
€103.16 Million
≈ $120.61 Million
0.248x -2.04%
2014-12-31 €379.88 Million
≈ $444.12 Million
€96.16 Million
≈ $112.42 Million
0.253x -7.32%
2013-12-31 €391.86 Million
≈ $458.12 Million
€107.02 Million
≈ $125.11 Million
0.273x +9.17%
2012-12-31 €354.16 Million
≈ $414.05 Million
€88.59 Million
≈ $103.58 Million
0.250x +56.78%
2011-12-31 €368.65 Million
≈ $430.99 Million
€58.82 Million
≈ $68.77 Million
0.160x +6.24%
2010-12-31 €343.84 Million
≈ $401.99 Million
€51.64 Million
≈ $60.37 Million
0.150x -41.34%
2009-12-31 €313.28 Million
≈ $366.25 Million
€80.20 Million
≈ $93.76 Million
0.256x +6.15%
2008-12-31 €271.49 Million
≈ $317.40 Million
€65.48 Million
≈ $76.55 Million
0.241x +7.40%
2007-12-31 €249.94 Million
≈ $292.21 Million
€56.13 Million
≈ $65.62 Million
0.225x +33.97%
2006-12-31 €230.09 Million
≈ $268.99 Million
€38.57 Million
≈ $45.09 Million
0.168x -7.68%
2005-12-31 €229.88 Million
≈ $268.75 Million
€41.74 Million
≈ $48.80 Million
0.182x -23.95%
2004-12-31 €144.09 Million
≈ $168.46 Million
€34.40 Million
≈ $40.22 Million
0.239x -2.79%
2003-12-31 €149.53 Million
≈ $174.82 Million
€36.73 Million
≈ $42.94 Million
0.246x -4.17%
2002-12-31 €134.47 Million
≈ $157.20 Million
€34.46 Million
≈ $40.29 Million
0.256x -8.21%
2001-12-31 €119.17 Million
≈ $139.32 Million
€33.27 Million
≈ $38.90 Million
0.279x --

About Boiron SA

PA:BOI France Drug Manufacturers - Specialty & Generic
Market Cap
$556.17 Million
€475.73 Million EUR
Market Cap Rank
#13010 Global
#194 in France
Share Price
€27.40
Change (1 day)
+4.58%
52-Week Range
€20.90 - €31.70
All Time High
€59.48
About

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more